Features

» cancer

Most Recent

image: A Different Way of Doing Things

A Different Way of Doing Things

By | April 1, 2016

Cancer cells exhibit altered metabolic processes that may serve as promising targets for new therapies.

0 Comments

image: Microbes Meet Cancer

Microbes Meet Cancer

By | April 1, 2016

Understanding cancer’s relationship with the human microbiome could transform immune-modulating therapies.

4 Comments

image: The Forces of Cancer

The Forces of Cancer

By | April 1, 2016

A tumor’s physical environment fuels its growth and causes treatment resistance.

0 Comments

image: Breaking the Cancer-Obesity Link

Breaking the Cancer-Obesity Link

By , and | November 1, 2015

Obese people are at higher risk for developing cancer, have worse prognoses once diagnosed, and are often resistant to chemotherapy regimens. The question is, Why?

2 Comments

image: My Mighty Mouse

My Mighty Mouse

By | April 1, 2015

Personal drug regimens based on xenograft mice harboring a single patient’s tumor still need to prove their true utility in medicine.

1 Comment

image: Resisting Cancer

Resisting Cancer

By | April 1, 2015

If one out of three people develops cancer, that means two others don’t. Understanding why could lead to insights relevant to prevention and treatment.

7 Comments

image: Tactical Maneuvers

Tactical Maneuvers

By | June 1, 2014

Scientists are creating viruses that naturally home in on tumor cells while simultaneously boosting the body’s immune system to fight cancer.

2 Comments

image: Deploying the Body’s Army

Deploying the Body’s Army

By | April 1, 2014

Using patients’ own immune systems to fight cancer

3 Comments

image: Models of Transparency

Models of Transparency

By , , and | April 1, 2013

Researchers are taking advantage of small, transparent zebrafish embryos and larvae—and a special strain of see-through adults—to understand the development and spread of cancer.

0 Comments

image: Targeting DNA

Targeting DNA

By | June 1, 2012

After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.

13 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech